MedCline™ Significantly Reduces Nocturnal Acid Reflux and Provides Quality of Life Improvements in Patients Unresponsive to GERD Medications

Approximately 20-30% of patients with gastroesophageal reflux disease (GERD) continue to suffer moderate to severe heartburn and regurgitation despite regular ProtonPump Inhibitor (PPI) usage. In its most recent clinical study, the MedCline reflux relief system significantly reduced nocturnal reflux symptoms and provided health-related quality of life improvements for these patients, providing much needed relief. The results of the study, “Use of Sleep Positioning Device Significantly Improves Nocturnal Gastroesophageal Reflux Symptoms,” were presented to the medical community by Dr. Scott Gabbard of Cleveland Clinic at the American College of Gastroenterology (ACG) Annual Scientific Meeting and Postgraduate Course 2014.

Upon enrollment into the study, patients completed the Nocturnal GERD Symptom Severity and Impact Questionnaire (N-GSSIQ). This validated questionnaire is comprised of three parts: (a) nocturnal GERD symptoms, (b) morning impact of GERD, and (c) concern about nocturnal GERD. Patients then used MedCline for two weeks for at least 6 hours per night, initiating sleep  on the left side. After two weeks, patients repeated the N-GSSIQ.

The results showed a significant reduction in scores across all measures using MedCline:

  • 77% reduction in nocturnal GERDsymptoms
  • 67% reduction in morning impact ofGERD
  • 61% reduction in concerns about nocturnalGERD

With a 72% reduction in overall N-GSSIQ scores, this study validates MedCline as an effective,at-home nocturnal acid reflux treatment which provides significant nighttime relief for GERD patients who continueto have symptoms despite PPIusage.

For more information about Amenity Heath clinical trial result, contact Aaron Clark at 858-605-1747.

###